Related references
Note: Only part of the references are listed.A Novel Chip for Cyclic Stretch and Intermittent Hypoxia Cell Exposures Mimicking Obstructive Sleep Apnea
Noelia Campillo et al.
FRONTIERS IN PHYSIOLOGY (2016)
Adipose tissue macrophage polarization by intermittent hypoxia in a mouse model of OSA: Effect of tumor microenvironment
Isaac Almendros et al.
CANCER LETTERS (2015)
Cyclooxygenase-2 inhibitors in lung cancer treatment: Bench to bed
Rui Liu et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2015)
Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration
I. Acerbi et al.
INTEGRATIVE BIOLOGY (2015)
Food intake, tumor growth, and weight loss in EP2 receptor subtype knockout mice bearing PGE2-producing tumors
Britt-Marie Iresjo et al.
PHYSIOLOGICAL REPORTS (2015)
Intermittent Hypoxia-induced Changes in Tumor-associated Macrophages and Tumor Malignancy in a Mouse Model of Sleep Apnea
Isaac Almendros et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2014)
COX-2 Signaling and Cancer: New Players in Old Arena
Shashank Misra et al.
CURRENT DRUG TARGETS (2014)
Prostaglandin E2 produced by inducible COX-2 and mPGES-1 promoting cancer cell proliferation in vitro and in vivo
Diana Ruan et al.
LIFE SCIENCES (2014)
Sleep apnea increased incidence of primary central nervous system cancers: a nationwide cohort study
Jin-Cherng Chen et al.
SLEEP MEDICINE (2014)
Sleep apnea awakens cancer A unifying immunological hypothesis
David Gozal et al.
ONCOIMMUNOLOGY (2014)
Targeting COX-2 abrogates mammary tumorigenesis Breaking cancer-associated suppression of immunosurveillance
Nune Markosyan et al.
ONCOIMMUNOLOGY (2014)
Increased Prevalence of Sleep-Disordered Breathing in Adults
Paul E. Peppard et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2013)
Association between Obstructive Sleep Apnea and Cancer Incidence in a Large Multicenter Spanish Cohort
Francisco Campos-Rodriguez et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2013)
The immunosuppressive tumour network: myeloid-derived suppressor cells, regulatory T cells and natural killer T cells
Dennis Lindau et al.
IMMUNOLOGY (2013)
Cyclooxygenase-2 Inhibition Blocks M2 Macrophage Differentiation and Suppresses Metastasis in Murine Breast Cancer Model
Yi-Rang Na et al.
PLOS ONE (2013)
Chronic Intermittent Hypoxia Exerts CNS Region-Specific Effects on Rat Microglial Inflammatory and TLR4 Gene Expression
Stephanie M. C. Smith et al.
PLOS ONE (2013)
Intermittent hypoxia increases melanoma metastasis to the lung in a mouse model of sleep apnea
Isaac Almendros et al.
RESPIRATORY PHYSIOLOGY & NEUROBIOLOGY (2013)
Sleep apnoea and metabolic dysfunction
Maria R. Bonsignore et al.
EUROPEAN RESPIRATORY REVIEW (2013)
Sleep-disordered Breathing and Cancer Mortality Results from the Wisconsin Sleep Cohort Study
F. Javier Nieto et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2012)
The presence of tumor associated macrophages in tumor stroma as a prognostic marker for breast cancer patients
Catharina Medrek et al.
BMC CANCER (2012)
Primary Tumor Hypoxia Recruits CD11b+/Ly6Cmed/Ly6G+ Immune Suppressor Cells and Compromises NK Cell Cytotoxicity in the Premetastatic Niche
Jaclyn Sceneay et al.
CANCER RESEARCH (2012)
Molecular Link Mechanisms between Inflammation and Cancer
D. B. Vendramini-Costa et al.
CURRENT PHARMACEUTICAL DESIGN (2012)
Intermittent hypoxia enhances cancer progression in a mouse model of sleep apnoea
I. Almendros et al.
EUROPEAN RESPIRATORY JOURNAL (2012)
Prostaglandin E2 (PGE2) suppresses natural killer cell function primarily through the PGE2 receptor EP4
Dawn Holt et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2011)
COX-2 inhibition alters the phenotype of tumor-associated macrophages from M2 to M1 in ApcMin/+ mouse polyps
Yuki Nakanishi et al.
CARCINOGENESIS (2011)
Effect of celecoxib on survival in patients with advanced non-small cell lung cancer: A double blind randomised clinical phase III trial (CYCLUS study) by the Swedish Lung Cancer Study Group
Andrea Koch et al.
EUROPEAN JOURNAL OF CANCER (2011)
Regulation of inflammation in cancer by eicosanoids
Emily R. Greene et al.
PROSTAGLANDINS & OTHER LIPID MEDIATORS (2011)
Microenvironmental Hypoxia Orchestrating the Cell Stroma Cross Talk, Tumor Progression and Antitumor Response
Muhammad Zaeem Noman et al.
CRITICAL REVIEWS IN IMMUNOLOGY (2011)
Identification of Cyclooxygenase-2 as a Major Actor of the Transcriptomic Adaptation of Endothelial and Tumor Cells to Cyclic Hypoxia: Effect on Angiogenesis and Metastases
Geraldine Daneau et al.
CLINICAL CANCER RESEARCH (2010)
COX-2 as a target for cancer chemotherapy
Nilanjan Ghosh et al.
PHARMACOLOGICAL REPORTS (2010)
The COX-2/PGE(2) pathway: key roles in the hallmarks of cancer and adaptation to the tumour microenvironment
Alexander Greenhough et al.
CARCINOGENESIS (2009)
Cyclooxygenase-2 (cox-2) blockade in the chemoprevention of cancers of the colon, breast, prostate, and lung
R. E. Harris
INFLAMMOPHARMACOLOGY (2009)
Antitumor enhancement of celecoxib, a selective Cyclooxygenase-2 inhibitor, in a Lewis lung carcinoma expressing Cyclooxygenase-2
Won Park et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2008)
Cross-talk between myeloid-derived suppressor cells and macrophages subverts tumor immunity toward a type 2 response
Pratima Sinha et al.
JOURNAL OF IMMUNOLOGY (2007)
Unphosphorylated STAT6 contributes to constitutive cyclooxygenase-2 expression in human non-small cell lung cancer
X. Cui et al.
ONCOGENE (2007)
Sleep apnoea as an independent risk factor for cardiovascular disease: current evidence, basic mechanisms and research priorities
W. T. McNicholas et al.
EUROPEAN RESPIRATORY JOURNAL (2007)
Host and direct antitumor effects and profound reduction in tumor metastasis with selective EP4 receptor antagonism
Li Yang et al.
CANCER RESEARCH (2006)
Direct transcriptional up-regulation of cyclooxygenase-2 by hypoxia-inducible factor (HIF)-1 promotes colorectal tumor cell survival and enhances HIF-1 transcriptional activity during hypoxia
Abderrahmane Kaidi et al.
CANCER RESEARCH (2006)
Role of tumor-associated macrophages in tumor progression and invasion
Alberto Mantovani et al.
CANCER AND METASTASIS REVIEWS (2006)
Cyclooxygenase inhibitors modulate NK activities that control metastatic disease
N Kundu et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2005)
Effects of celecoxib in human retinoblastoma cell lines and in a transgenic murine model of retinoblastoma
CT Tong et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2005)
Prostaglandin E and prostacyclin receptor expression in tumor and host tissues from MCG 101-bearing mice: A model with prostanoid-related cachexia
WH Wang et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
Macrophage responses to hypoxia - Implications for tumor progression and anti-cancer therapies
C Lewis et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
Cyclooxygenase 2 and intermittent hypoxia-induced spatial deficits in the rat
RC Li et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2003)
Prostanoids play a major role in the primary tumor-induced inhibition of dendritic cell differentiation
CC Sombroek et al.
JOURNAL OF IMMUNOLOGY (2002)
Regulation of constitutive cyclooxygenase-2 expression in colon carcinoma cells
JY Shao et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Share Paper
